Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000912057-96-017827
Filing Date
1996-08-14
Accepted
1996-08-14 00:00:00
Documents
18
Period of Report
1996-06-30
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q 10-Q 147648
2 CERT. OF AMEND OF RESTAT. CERT OF INC. EX-3.04 11845
3 SECOND SUPPLEMENTAL INDENTURE EX-4.03 42146
4 EXHIBIT 4.09 EX-4.09 3096
5 EXHIBIT 10.24 EX-10.24 24234
6 EXH 10.56 EX-10.56 49237
7 EXHIBIT 10.86 EX-10.86 268871
8 ROYALTY PROJECTS AGRMT EX-10.87 55473
9 LETTER AGRMT BETWN CHIRON AND DR. BARKER EX-10.88 4369
10 REVOLVING CREDIT AGREEMENT EX-10.89 19493
11 PURCHASE AGREEMENT BETWEEN BNP AND CHIRON EX-10.90 231515
12 LEASE AGREEMENT BETWEEN BNP AND CHIRON EX-10.91 360884
13 GROUND LEASE BETWEEN BNP ANS CHIRON EX-10.92 258430
14 REIMBURS. AGMT BTWN CIBA-GEIGY & CHIRON EX-10.93 8840
15 REIMBURS. AGMT BTWN CIBA-GEIGY & CHIRON EX-10.94 9037
16 REIMBURS. AGMT BTWN CIBA-GEIGY & CHIRON EX-10.95 9311
17 STATEMENT OF COMPUTATION OF EARNINGS PER SHAR EX-11 4295
18 FINANCIAL DATA SCHEDULE EX-27 3050
  Complete submission text file 0000912057-96-017827.txt   1514920
Mailing Address
Business Address 4560 HORTON ST EMERYVILLE CA 94608 5106558730
CHIRON CORP (Filer) CIK: 0000706539 (see all company filings)

EIN.: 942754624 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12798 | Film No.: 96613659
SIC: 2834 Pharmaceutical Preparations